Stock listing

NASDAQ:KVAC Keen Vision Acquisition Corporation Stock

Home listing (NASDAQ) of Keen Vision Acquisition Corporation

Follow Keen Vision Acquisition Corporation into a list and get an email when it puts out news.

Keen Vision Acquisition Corporation logo
Ticker
NASDAQ:KVAC
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Latest news

Medera and University of Kansas Medical Center Announce First Patient Treated in Pioneering Gene Therapy Trial for Duchenne Muscular Dystrophy Associated Cardiomyopathy

Jul 15, 2025

Medera’s Novoheart Enters New Collaboration to Develop Human Mini-Heart Models Aimed at Transforming Treatment for Hypoplastic Left Heart Syndrome

Jun 24, 2025

Medera Showcased Positive Interim Data From First-in-Human Gene Therapy Trial for HFpEF in Late-Breaking Presentation at Heart Failure 2025 Congress

May 19, 2025

Medera to Present Late-Breaking Phase 1/2a Clinical Trial Results at Heart Failure 2025 Congress

May 12, 2025

Financial Obligation Form 8 K

Nov 26, 2024

Quarterly Report for Quarter Ending September 30, 2024 (Form 10-Q)

Nov 4, 2024

All Keen Vision Acquisition Corporation news

Keen Vision Acquisition Corporation on 6ix

News releases
6 in all · newest Jul 15, 2025 · oldest 2024

Where Keen Vision Acquisition Corporation is listed

ListingExchangeCountryCurrency
NASDAQ:KVAC · Home listing · This pageNASDAQUnited StatesUSD
BOATS:KVACBOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about Keen Vision Acquisition Corporation.